加载页面时好像出了点问题.
我们的团队已经注意到了，但如果问题仍然存在，请使用电子邮件支持小工具联系我们。
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | No |
| Is net profit margin increasing? | Yes | Yes |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | No | Yes |
| Competitors Used |
|---|
| Xlife Sciences AG |
| Evotec SE |
| Pangaea Oncology, S.A. |
| Nanoform Finland Oyj |
| Lonza Group AG |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| XLS | EVT | PANG | 4YL | LONN | PPGN | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 8% | -16% | -30% | -37% | 7% | -5% | ||
| Fiscal Year - 1 | 6% | -14% | -15% | -27% | 7% | -13% | ||
| Fiscal Year - 2 | 31% | 21% | -6% | -26% | 12% | 2% | ||
| Fiscal Year - 3 | 19% | 1% | -21% | -27% | 8% | 16% | ||
| Fiscal Year - 4 | 1% | 8% | -58% | -55% | 11% | 19% | ||
| Fiscal Year - 5 | NA | 22% | -18% | -117% | 10% | 17% | ||
| Average | 13% | 4% | -25% | -48% | 9% | 6% | ||
| Median | 8% | 5% | -20% | -32% | 9% | 9% | ||
| Benchmarks | Ticker | |||||||
| Xlife Sciences AG | SWX:XLS | |||||||
| Evotec SE | BRSE:EVT | |||||||
| Pangaea Oncology, S.A. | BME:PANG | |||||||
| Nanoform Finland Oyj | DB:4YL | |||||||
| Lonza Group AG | SWX:LONN | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | XLS | EVT | PANG | 4YL | LONN | PPGN | ||
| Latest Fiscal Year | Dec-23 | Dec-23 | Dec-23 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Jun-24 | Sep-24 | Jun-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 1 | 777 | 14 | 4 | 6,574 | 337 | ||
| Fiscal Year | 1 | 781 | 10 | 4 | 6,574 | 337 | ||
| Fiscal Year - 1 | 1 | 751 | 7 | 3 | 6,717 | 320 | ||
| Fiscal Year - 2 | 1 | 618 | 7 | 3 | 6,223 | 281 | ||
| Fiscal Year - 3 | 0 | 501 | 6 | 2 | 5,409 | 282 | ||
| Fiscal Year - 4 | 1 | 446 | 6 | 1 | 4,508 | 224 | ||
| Fiscal Year - 5 | NA | 375 | 6 | 0 | 4,207 | 203 | ||
| Net Income | ||||||||
| Latest Twelve Months | 21 | (171) | (5) | (23) | 636 | (20) | ||
| Fiscal Year | 15 | (84) | (5) | (23) | 636 | (20) | ||
| Fiscal Year - 1 | 14 | (176) | (3) | (21) | 654 | (51) | ||
| Fiscal Year - 2 | 53 | 216 | (1) | (22) | 1,215 | 8 | ||
| Fiscal Year - 3 | 21 | 6 | (2) | (20) | 674 | 47 | ||
| Fiscal Year - 4 | 1 | 38 | (5) | (19) | 730 | 31 | ||
| Fiscal Year - 5 | NA | 84 | (1) | (8) | 647 | 26 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 478 | 2,255 | 25 | 78 | 16,848 | 689 | ||
| Latest Fiscal Quarter | 510 | 1,991 | 27 | 72 | 19,733 | 757 | ||
| Fiscal Year | 512 | 2,252 | 29 | 72 | 19,733 | 757 | ||
| Fiscal Year - 1 | 490 | 2,257 | 28 | 78 | 16,848 | 689 | ||
| Fiscal Year - 2 | 480 | 2,235 | 21 | 101 | 17,356 | 576 | ||
| Fiscal Year - 3 | 186 | 1,462 | 17 | 99 | 16,459 | 595 | ||
| Fiscal Year - 4 | 154 | 1,181 | 17 | 74 | 14,429 | 376 | ||
| Fiscal Year - 5 | NA | 772 | 20 | 13 | 13,841 | 305 | ||
| Fiscal Year - 6 | NA | 666 | 19 | 8 | 13,921 | 284 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 233 | 1,141 | 20 | 67 | 9,452 | 381 | ||
| Latest Fiscal Quarter | 273 | 968 | 16 | 60 | 9,328 | 357 | ||
| Fiscal Year | 268 | 1,120 | 18 | 60 | 9,328 | 357 | ||
| Fiscal Year - 1 | 235 | 1,187 | 23 | 67 | 9,452 | 381 | ||
| Fiscal Year - 2 | 211 | 1,378 | 14 | 87 | 10,597 | 422 | ||
| Fiscal Year - 3 | 130 | 724 | 8 | 84 | 9,750 | 421 | ||
| Fiscal Year - 4 | 97 | 477 | 8 | 63 | 6,815 | 178 | ||
| Fiscal Year - 5 | NA | 424 | 9 | 8 | 6,494 | 149 | ||
| Fiscal Year - 6 | NA | 331 | 5 | 5 | 6,218 | 148 | ||